BA SX & COSMETIC SX · Consensus Statement for Asian Indians: *The pharmacotherapy should be...

29
BA SX & COSMETIC SX :: SEPERATING FACTS FROM FICTION Dr Jayasshree S Todkar Director, JT Foundation, International Center of Excellence for Bariatric & Metabolic Surgery ,India Secretary : Obesity Surgery Society of India 9823090505 [email protected] www.drjayashreetodkar.c

Transcript of BA SX & COSMETIC SX · Consensus Statement for Asian Indians: *The pharmacotherapy should be...

Page 1: BA SX & COSMETIC SX · Consensus Statement for Asian Indians: *The pharmacotherapy should be initiated for BMI above 27 kg/m2 without co-morbidity, or a BMI above 25 kg/ m2 with co-morbidity.

BA SX & COSMETIC SX::

SEPERATING FACTS FROM FICTION

Dr Jayasshree S Todkar

Director, JT Foundation,

International Center of Excellence for Bariatric & Metabolic Surgery ,India

• Secretary : • Obesity Surgery Society

of India• 9823090505• [email protected]• www.drjayashreetodkar.c

om

Page 2: BA SX & COSMETIC SX · Consensus Statement for Asian Indians: *The pharmacotherapy should be initiated for BMI above 27 kg/m2 without co-morbidity, or a BMI above 25 kg/ m2 with co-morbidity.

OBESITY ---GLOBAL EPIDEMIC (WHO)

Page 3: BA SX & COSMETIC SX · Consensus Statement for Asian Indians: *The pharmacotherapy should be initiated for BMI above 27 kg/m2 without co-morbidity, or a BMI above 25 kg/ m2 with co-morbidity.

53yrs, Eng,DM 15 yrs on Insulin, HT,IHD with A’plasty done,

Br. Asthma, Sleep Apnea on CPAP,

HypothyroidismSTRESS INCONTINENCE

Page 4: BA SX & COSMETIC SX · Consensus Statement for Asian Indians: *The pharmacotherapy should be initiated for BMI above 27 kg/m2 without co-morbidity, or a BMI above 25 kg/ m2 with co-morbidity.

48 yr old, DM on OHAs,

HT, V.V with ulcers,

Abd hernia, (past Abd’plasty)

, Breathless on slight

exertion

DUB

Page 5: BA SX & COSMETIC SX · Consensus Statement for Asian Indians: *The pharmacotherapy should be initiated for BMI above 27 kg/m2 without co-morbidity, or a BMI above 25 kg/ m2 with co-morbidity.

HERNIAS , VARICOSE VEINS

Page 6: BA SX & COSMETIC SX · Consensus Statement for Asian Indians: *The pharmacotherapy should be initiated for BMI above 27 kg/m2 without co-morbidity, or a BMI above 25 kg/ m2 with co-morbidity.
Page 7: BA SX & COSMETIC SX · Consensus Statement for Asian Indians: *The pharmacotherapy should be initiated for BMI above 27 kg/m2 without co-morbidity, or a BMI above 25 kg/ m2 with co-morbidity.

28 yr old, 380kg,Teacher for B.Com Students, Obese since childhood,Hyperlipidemia, Hyperinsulinemia,Breathlessness on exertion,Amenorrhoea x 9 yrs

Page 8: BA SX & COSMETIC SX · Consensus Statement for Asian Indians: *The pharmacotherapy should be initiated for BMI above 27 kg/m2 without co-morbidity, or a BMI above 25 kg/ m2 with co-morbidity.

OBESITY COMES WITH

BAGGAGE

Page 9: BA SX & COSMETIC SX · Consensus Statement for Asian Indians: *The pharmacotherapy should be initiated for BMI above 27 kg/m2 without co-morbidity, or a BMI above 25 kg/ m2 with co-morbidity.
Page 10: BA SX & COSMETIC SX · Consensus Statement for Asian Indians: *The pharmacotherapy should be initiated for BMI above 27 kg/m2 without co-morbidity, or a BMI above 25 kg/ m2 with co-morbidity.
Page 11: BA SX & COSMETIC SX · Consensus Statement for Asian Indians: *The pharmacotherapy should be initiated for BMI above 27 kg/m2 without co-morbidity, or a BMI above 25 kg/ m2 with co-morbidity.

OBESITY COMES WITH

BAGGAGE : yes

NEEDS COMPLETE TREATMENT : YESSS

Page 12: BA SX & COSMETIC SX · Consensus Statement for Asian Indians: *The pharmacotherapy should be initiated for BMI above 27 kg/m2 without co-morbidity, or a BMI above 25 kg/ m2 with co-morbidity.
Page 13: BA SX & COSMETIC SX · Consensus Statement for Asian Indians: *The pharmacotherapy should be initiated for BMI above 27 kg/m2 without co-morbidity, or a BMI above 25 kg/ m2 with co-morbidity.

“Bariatric”

Surgery

Page 14: BA SX & COSMETIC SX · Consensus Statement for Asian Indians: *The pharmacotherapy should be initiated for BMI above 27 kg/m2 without co-morbidity, or a BMI above 25 kg/ m2 with co-morbidity.

Consensus Statement for Asian Indians:

*The pharmacotherapy should be initiated for BMI above 27 kg/m2 without co-morbidity, or a BMI above 25 kg/ m2 with co-morbidity.

*The cut-offs for WC for initiating medical help:Males >90 cms,Females > 80 cms

*Bariatric Surgery: Consensus Statement for Asian Indians:

BMI above 32.5 kg/m2 with co-morbidity, and BMI above 37.5 kg/m2 without co-morbidity.

Page 15: BA SX & COSMETIC SX · Consensus Statement for Asian Indians: *The pharmacotherapy should be initiated for BMI above 27 kg/m2 without co-morbidity, or a BMI above 25 kg/ m2 with co-morbidity.

Benefits of Bariatric Surgery

1. Reduced weight leads to increased socio-economic status.

2. Increases confidence.3. Improved performance on day to day basis.4. Relief of symptoms of menses, infertility, PCOS.5. Healthy pregnancy therefore healthy mother

and healthy child.6. Resolved obesity related co-morbidities.7. Resolved obesity related pregnancy issues.8. Lowered risk of Cancer in women.

Page 16: BA SX & COSMETIC SX · Consensus Statement for Asian Indians: *The pharmacotherapy should be initiated for BMI above 27 kg/m2 without co-morbidity, or a BMI above 25 kg/ m2 with co-morbidity.
Page 17: BA SX & COSMETIC SX · Consensus Statement for Asian Indians: *The pharmacotherapy should be initiated for BMI above 27 kg/m2 without co-morbidity, or a BMI above 25 kg/ m2 with co-morbidity.

DIFFERENT PROCEDURES GOOD RESULTS !

Page 18: BA SX & COSMETIC SX · Consensus Statement for Asian Indians: *The pharmacotherapy should be initiated for BMI above 27 kg/m2 without co-morbidity, or a BMI above 25 kg/ m2 with co-morbidity.

Clev Clin J Med, 2006

Page 19: BA SX & COSMETIC SX · Consensus Statement for Asian Indians: *The pharmacotherapy should be initiated for BMI above 27 kg/m2 without co-morbidity, or a BMI above 25 kg/ m2 with co-morbidity.
Page 20: BA SX & COSMETIC SX · Consensus Statement for Asian Indians: *The pharmacotherapy should be initiated for BMI above 27 kg/m2 without co-morbidity, or a BMI above 25 kg/ m2 with co-morbidity.

Changes

in

Gut Hormones

Page 21: BA SX & COSMETIC SX · Consensus Statement for Asian Indians: *The pharmacotherapy should be initiated for BMI above 27 kg/m2 without co-morbidity, or a BMI above 25 kg/ m2 with co-morbidity.
Page 22: BA SX & COSMETIC SX · Consensus Statement for Asian Indians: *The pharmacotherapy should be initiated for BMI above 27 kg/m2 without co-morbidity, or a BMI above 25 kg/ m2 with co-morbidity.
Page 23: BA SX & COSMETIC SX · Consensus Statement for Asian Indians: *The pharmacotherapy should be initiated for BMI above 27 kg/m2 without co-morbidity, or a BMI above 25 kg/ m2 with co-morbidity.
Page 24: BA SX & COSMETIC SX · Consensus Statement for Asian Indians: *The pharmacotherapy should be initiated for BMI above 27 kg/m2 without co-morbidity, or a BMI above 25 kg/ m2 with co-morbidity.
Page 25: BA SX & COSMETIC SX · Consensus Statement for Asian Indians: *The pharmacotherapy should be initiated for BMI above 27 kg/m2 without co-morbidity, or a BMI above 25 kg/ m2 with co-morbidity.
Page 26: BA SX & COSMETIC SX · Consensus Statement for Asian Indians: *The pharmacotherapy should be initiated for BMI above 27 kg/m2 without co-morbidity, or a BMI above 25 kg/ m2 with co-morbidity.
Page 27: BA SX & COSMETIC SX · Consensus Statement for Asian Indians: *The pharmacotherapy should be initiated for BMI above 27 kg/m2 without co-morbidity, or a BMI above 25 kg/ m2 with co-morbidity.

LRYGBP 2003

Page 28: BA SX & COSMETIC SX · Consensus Statement for Asian Indians: *The pharmacotherapy should be initiated for BMI above 27 kg/m2 without co-morbidity, or a BMI above 25 kg/ m2 with co-morbidity.

Dr Jayasshree S [email protected]

9823090505www.drjayashreetodkar.com

Page 29: BA SX & COSMETIC SX · Consensus Statement for Asian Indians: *The pharmacotherapy should be initiated for BMI above 27 kg/m2 without co-morbidity, or a BMI above 25 kg/ m2 with co-morbidity.

Gall stone disease in the severely obese : liver, visceral fat & other

hurdles

Dr Jayasshree S Todkkar

Apollo spectra Hospital,

Pune